Cytokines in alcoholic and nonalcoholic steatohepatitis

New England Journal of Medicine

Volumn 343, Issue 20, 2000, Pages 1467-1467

  Tilg, Herbert ^a   Diehl, Anna Mae ^b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTILIPEMIC AGENT; CYTOKINE; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; GEMFIBROZIL; GLUCOCORTICOID; GLUTATHIONE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; LEPTIN; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; URSODEOXYCHOLIC ACID;

ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; DETOXIFICATION; FATTY LIVER; HUMAN; IMMUNE SYSTEM; LIVER CELL; LIVER DISEASE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CHRONIC DISEASE; CYTOKINES; DISEASE PROGRESSION; FATTY LIVER; HEPATOCYTES; HUMANS; LIVER DISEASES, ALCOHOLIC; OBESITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034676629     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200011163432007     Document Type: Review

References (102)

1. Biologic basis for interleukin-1 in disease
2. Tumor necrosis factor, other cytokines and disease
3. T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin-6
4. Mechanisms for virus-induced liver disease: Tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection
5. Molecular pathogenesis of cholestasis
6. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
7. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy
8. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
9. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
10. Histologic spectrum of alcoholic liver disease
11. Alcoholic liver disease: New insights in pathogenesis lead to new treatments
12. Ethanol oxidizing enzymes: Roles in alcohol metabolism and alcoholic liver disease
13. The interaction of alcoholic liver disease and hepatitis C
14. Cytokines and alcoholic liver disease
15. Histologic course of alcoholic hepatitis: Influence of abstinence, sex and extent of hepatic damage
16. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials
17. Biologically active products of stimulated liver macrophages (Kupffer cells)
18. Acute-phase response factor, increased binding, and target gene transcription during liver regeneration
19. Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats
20. Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury
21. Signalling by CD95 and TNF receptors: Not only life and death
22. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions: Evidence for the involvement of mitochondrial radical generation
23. Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function
24. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest
25. Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes
26. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1
27. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms
28. Impaired liver regeneration in inducible nitric oxide synthase-deficient mice
29. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance
30. A pivotal role of IL-12 in Th1-dependent mouse liver injury
31. Interferon gamma receptor deficient mice are resistant to endotoxic shock
32. IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock
33. Increased plasma tumor necrosis factor in severe alcoholic hepatitis
34. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis
35. Serum interleukin-1 (IL-1) activity in alcoholic hepatitis
36. Increased plasma interleukin-6 concentrations in alcoholic hepatitis
37. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration
38. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: Reevaluation with an improved chromogenic assay
39. Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis
40. Serum levels of cytokines in chronic liver diseases
41. Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease
42. Ethanol-induced liver fibrosis in rats fed high fat diets
43. Severity of liver injury in experimental alcoholic liver disease: Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2
44. Antibiotics prevent liver injury in rats following long-term exposure to ethanol
45. Lactobaclilus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease)
46. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat
47. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice
48. Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver
49. Kupffer cell depletion by gadolinium chloride enhances liver regeneration after partial hepatectomy in rats
50. GSH transport in mitochondria: Defense against TNF-induced oxidative stress and alcohol-induced defect
51. The mitochondrial death/life regulator in apoptosis and necrosis
52. Giant mitochondria in hepatocytes: A diagnostic hint for alcoholic liver disease
53. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase
54. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal perivenous rat hepatocytes
55. Impaired mitochondrial function in microvesicular steatosis: Effects of drugs, ethanol, hormones and cytokines
56. Subcellular changes and apoptosis induced by ethanol in rat liver
57. Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats
58. Alcohol and cytokine-inducible transcription factors
59. Nonalcoholic steatohepatitis
60. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
61. Effects of the obese gene product on body weight regulation in ob/ob nice
62. Leptin receptor missense mutation in the fatty Zucker rat
63. Cellular mechanisms of insulin resistance in humans
64. Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis
65. Leptin regulates proinflammatory immune responses
66. Phenotypic abnormalities in macrophages from leptin-deficient, obese mice
67. Enhanced oxidative metabolism in liver mitochondria from genetically obese mice
68. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion
69. Mirochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver
70. Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha)
71. Up-regulation of UCP-2 gene expression by PPAR agonists in preadipose and adipose cells
72. Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia
73. Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression
74. The uncoupling proteins, a review
75. Mitochondrial uncoupling: Role of uncoupling protein anion carriers and relationship to thermogenesis and weight control 'the benefits of losing control'
76. Leptin deficiency enhances sensitivity to endotoxin-induced lethality
77. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor
78. Subcellular localization of uncoupling protein (UCP)2 and evidence for increased UCP2 expression in nonalcoholic steatohepatitis
79. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study
80. Liver regeneration
81. Complications of cirrhosis. I. Portal hypertension
82. Prolonged activation of jun and collagenase genes by tumor necrosis factor-alpha
83. LAP (NF-IL6) transactivates the collagen alpha 1(I) gene from a 5' regulatory region
84. Nitric oxide and portal hypertension: Its role in the regulation of intrahepatic and splanchnic vascular resistance
85. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis
86. Effect of weight reduction on hepatic abnormalities in overweight patients
87. Fasting in obesity: Another cause of liver injury with alcoholic hyaline?
88. Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats
89. Feeding S-adcnosyl-L-methionine attenuates both ethanol-induced depiction of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes
90. Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic disease
91. The effect of betaine in reversing alcoholic steatosis
92. Increased hepatocytc CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation
93. Long-term treatment of alcoholic liver disease with propylthiouracil
94. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver
95. Effects of oral S-adenosyl-L-methionine on hepatic gluthathione in patients with liver disease
96. Effects of long-term vitamin E supplementation in alcoholic cirrhotics
97. Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients
98. Two cases from the spectrum of nonalcoholic steatohepatitis
99. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function
100. Association of nonalcoholic fatty liver disease with insulin resistance
101. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy
102. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy